Citation Impact
Citing Papers
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
1991 Standout
Identification of a Neutralizing Domain in the External Envelope Glycoprotein of Simian Immunodeficiency Virus
1992
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 Standout
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 StandoutNature
Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine
1990
Combined antiviral effects of paired nucleosides against guinea pig cytomegalovirus replication in vitro
1990
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
2011 Standout
Immunization with Tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection
1992
Innate Immunity: The Virtues of a Nonclonal System of Recognition
1997 Standout
Inhibition of Simian varicella virus infection of monkeys by 1-(2-deoxy-2-fluoro-1-β-d-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-β
1990
The recognition event between virus and host cell receptor: a target for antiviral agents
1990
Adjuvants: current status, clinical perspectives and future prospects
1993
International Collaboration Comparing Neutralization and Binding Assays for Monoclonal Antibodies to Simian Immunodeficiency Virus
1993
HIV vaccines 1983–2003
2003
Strategies for an HIV vaccine
2002
Structure of Dengue Virus
2002 Standout
Evaluation of synergism or antagonism for the combined action of antiviral agents
1990
The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation
1998
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys
1991 Nature
Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus
1996
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
1993 StandoutNature
New advances in our understanding of the “unique” RNase L in host pathogen interaction and immune signaling
2016
Phosphorothioate analogs of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease
1987 StandoutNobel
Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.
1997
A High Affinity Binding Site for the HIV-1 Nucleocapsid Protein
1997 StandoutNobel
Virus Entry into Animal Cells
1989
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
1999 StandoutNature
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
1997
Studying the Binding and Entry of the Intracellular and Extracellular Enveloped Forms of Vaccinia Virus
2004
A three-dimensional model to analyze drug-drug interactions
1990
HIV as the cause of AIDS
1996 StandoutNobel
Immune Responses to SIV mne Envelope Glycoproteins Protect Macaques from Homologous SIV Infection
1992
Retroviral vectors displaying functional antibody fragments
1993 StandoutNobel
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection
1991
Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines
1991 Nature
Identification of Broadly Reactive Continuous Antigenic Determinants of Simian Immunodeficiency Virus Glycoproteins
1992
Vaccine Protection of Rhesus Macaques Against Simian Immunodeficiency Virus Infection
1990
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
The TNF and TNF Receptor Superfamilies
2001 Standout
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Nod1 and Nod2 induce CCL5/RANTES through the NF‐κB pathway
2007
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
2011 StandoutNobel
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
1989 Standout
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
A Very Large Metallosupramolecular Capsule with Cube-like 43 Topology Assembled from Twelve Cu(II) Centers and Eight Tri-Bidentate Tri-Anionic Ligands Derived from 2,4,6-Triphenylazo-1,3,5-trihydroxybenzene
1999 StandoutNobel
Protein structure determination in solution by NMR spectroscopy.
1990 StandoutNobel
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
1991 StandoutNobel
Mechanism of interferon action. Purification and substrate specificities of the double-stranded RNA-dependent protein kinase from untreated and interferon-treated mouse fibroblasts.
1985
Progress Toward an HIV Vaccine
2002
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus
2004 StandoutNobel
Protection of Macaques Against SIV Infection by Subunit Vaccines of SIV Envelope Glycoprotein gp160
1992 Science
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Increased stability and antiviral activity of 2′‐O‐phosphoglyceryl derivatives of (2′‐5′)oligo(adenylate)
1984
2-5A synthetase: assay, distribution and variation with growth or hormone status
1979 Nature
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha.
1988
Different transforming growth factor-α species are derived from a glycosylated and palmitoylated transmembrane precursor
1987
Fibroblast Growth Factor Receptor Is a Portal of Cellular Entry for Herpes Simplex Virus Type 1
1990 Science
Evidence for Recombination of Live, Attenuated Immunodeficiency Virus Vaccine with Challenge Virus to a More Virulent Strain
2000
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation
1986
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.
1979 StandoutNobel
Efficacy of inactivated whole HIV‐2 vaccines with various adjuvants in cynomolgus monkeys
1994
Regulation of cell proliferation and differentiation by interferons
1985
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine
1996
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2
1997
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Analogs of (2‘-5‘)oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells.
1981
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Pathogenesis of human immunodeficiency virus infection
1993
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene
1992 Science
Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
1985 StandoutScience
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
The biology of cancer metastasis and implications for therapy
1987
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus
1990
Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge
1994
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences.
1991
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
1993 StandoutScience
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Adjuvants: current status, clinical perspectives and future prospects
1993
The Trojan exosome hypothesis
2003
Interferon Action: RNA Cleavage Pattern of a (2′-5′)Oligoadenylate—Dependent Endonuclease
1981 Science
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates
1992
The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.
1992
Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry.
1987 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma.
1995 StandoutNobel
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex.
1990
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines
1994
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
1993 StandoutScience
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection
1993
Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
1990
n-Decyl-NHpppA2′p5′A2′p5′A a phosphatase-resistant, active pppA2′p5′A2′p5′A analog
1985 StandoutNobel
Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine
1992
Works of Deborah A. Eppstein being referenced
Dephosphorylated Core of 2′-5′ Oligoadenylate Exerts Its Antimitogenic Effect through Mechanisms Different from the 2′-5′A-Dependent Endonuclease
1983
Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models
1993
Mechanism of interferon action Kinetics of interferon action in mouse L929 cells: Translation inhibition, protein phosphorylation, and messenger RNA methylation and degradation
1977
Efficacy of SIV/DeltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys
1991
Growth Regulation of Melanoma Cells by Interferon and (2′-5′)Oligoadenylate Synthetase
1983
Mechanism of interferon action: Synthesis and activity of the interferon-mediated low-molecular-weight oligonucleotide from murine and human cells
1979
Prophylaxis and treatment of experimental lung metastases in mice after treatment with liposome-encapsulated 6-O-stearoyl-N-acetylmuramyl-L-?-aminobutyryl-D-isoglutamine
1984
Analogs of (A2'p)nA. Correlation of structure of analogs of ppp(A2'p)2A and (A2'p)2A with stability and biological activity.
1982
A Formalin-Inactivated Whole SIV Vaccine Confers Protection in Macaques
1989 Science
Cordycepin analogs of ppp5'A2‘p5'A2‘p5'A (2-5A) inhibit protein synthesis through activation of the 2-5A-dependent endonuclease.
1985
Xyloadenosine analogue of (A2′p)2A inhibits replication of herpes simplex viruses 1 and 2
1983 Nature
Stereoconfiguration markedly affects the biochemical and biological properties of phosphorothioate analogs of 2-5A core, (A2'p5')2A.
1986
Alternative delivery systems for peptides and proteins as drugs.
1988
Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase.
1983
Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy) methyl]guanine in combination with recombinant interferons
1984
Mechanism of interferon action Properties of an interferon-mediated ribonucleolytic activity from mouse L9z9 cells
1978
Effect of 9-(1,3-Dihydroxy-2-PropoxymethyI)Guanine and Recombinant Human Interferon Alone and in Combination on Simian Varicella Virus Infection in Monkeys
1987
Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with gamma interferon against herpes simplex virus type 2 in mice
1985
Epidermal growth factor receptor occupancy inhibits vaccinia virus infection
1985 Nature